AVACINCAPTAD PEGOL

AVACINCAPTAD PEGOL was reported 352 times

These side effects are most commonly reported by patients taking AVACINCAPTAD PEGOL:

# Side effect Count
0 VISUAL IMPAIRMENT 26
1 INTERCEPTED PRODUCT PREPARATION ERROR 25
2 EYE PAIN 24
3 NO ADVERSE EVENT 24
4 NEEDLE ISSUE 23
5 OFF LABEL USE 22
6 VISION BLURRED 22
7 SYRINGE ISSUE 18
8 ENDOPHTHALMITIS 16
9 PRODUCT TEMPERATURE EXCURSION ISSUE 16
10 CHOROIDAL NEOVASCULARISATION 15
11 INTRAOCULAR PRESSURE INCREASED 15
12 EYE INFLAMMATION 14
13 BLINDNESS TRANSIENT 13
14 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13
15 PRODUCT PACKAGING QUANTITY ISSUE 13
16 VITRITIS 13
17 PRODUCT STORAGE ERROR 12
18 UVEITIS 12
19 DEVICE ISSUE 11
20 INTERCEPTED PRODUCT STORAGE ERROR 11
21 VITREOUS FLOATERS 11
22 CONDITION AGGRAVATED 10
23 IRITIS 9
24 PRODUCT CONTAMINATION 9
25 PRODUCT PACKAGING ISSUE 9
26 VISUAL ACUITY REDUCED 9
27 EYE IRRITATION 8
28 INTERCEPTED PRODUCT ADMINISTRATION ERROR 8
29 DRUG INEFFECTIVE 7
30 HEADACHE 7
31 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 7
32 NON-INFECTIOUS ENDOPHTHALMITIS 7
33 OCULAR HYPERAEMIA 7
34 CORNEAL OEDEMA 5
35 CYSTOID MACULAR OEDEMA 5
36 DEATH 5
37 DRUG HYPERSENSITIVITY 5
38 EYE DISORDER 5
39 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 5
40 OPTIC ISCHAEMIC NEUROPATHY 5
41 PRODUCT PACKAGING DIFFICULT TO OPEN 5
42 CONFUSIONAL STATE 4
43 DRY AGE-RELATED MACULAR DEGENERATION 4
44 EYE HAEMORRHAGE 4
45 EYE INFECTION 4
46 EYE PRURITUS 4
47 OCULAR HYPERTENSION 4
48 PHOTOPSIA 4
49 POOR QUALITY PRODUCT ADMINISTERED 4
50 PRODUCT CONTAMINATION PHYSICAL 4
51 SOMNOLENCE 4
52 SUSPECTED OFF LABEL USE 4
53 BACTERIAL ENDOPHTHALMITIS 3
54 BLINDNESS 3
55 EYE OEDEMA 3
56 FATIGUE 3
57 GLAUCOMA 3
58 GRIP STRENGTH DECREASED 3
59 HYPOTENSION 3
60 LACRIMATION INCREASED 3
61 MACULAR CYST 3
62 OCULOCARDIAC REFLEX 3
63 RETINAL HAEMORRHAGE 3
64 RETINAL OCCLUSIVE VASCULITIS 3
65 RETINAL VASCULITIS 3
66 VITREOUS DETACHMENT 3
67 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3
68 BLINDNESS UNILATERAL 2
69 CATARACT 2
70 CHILLS 2
71 CHORIORETINITIS 2
72 COGNITIVE DISORDER 2
73 CORNEAL ABRASION 2
74 COUGH 2
75 DIARRHOEA 2
76 DISEASE PROGRESSION 2
77 DIZZINESS POSTURAL 2
78 DRY EYE 2
79 DYSCHROMATOPSIA 2
80 EXOPHTHALMOS 2
81 EYE DISCHARGE 2
82 EYE SWELLING 2
83 FEELING ABNORMAL 2
84 HYPERSENSITIVITY 2
85 HYPOTONY OF EYE 2
86 INJECTION SITE PAIN 2
87 INTENTIONAL DOSE OMISSION 2
88 INTERCEPTED MEDICATION ERROR 2
89 INTRA-OCULAR INJECTION COMPLICATION 2
90 IRIDOCYCLITIS 2
91 LETHARGY 2
92 LIQUID PRODUCT PHYSICAL ISSUE 2
93 MACULAR DEGENERATION 2
94 OCULAR VASCULITIS 2
95 PAIN 2
96 PRODUCT CLOSURE ISSUE 2
97 PRODUCT CONTAINER ISSUE 2
98 PRODUCT DOSE OMISSION ISSUE 2
99 PRODUCT OUTER PACKAGING ISSUE 2
100 PRODUCT PACKAGE ASSOCIATED INJURY 2
101 PRODUCT QUALITY ISSUE 2
102 PSEUDOPHAKIA 2
103 RETINAL DEGENERATION 2
104 RETINAL ISCHAEMIA 2
105 RETINAL OEDEMA 2
106 RETINAL VEIN OCCLUSION 2
107 SEDATION 2
108 UNDERDOSE 2
109 URTICARIA 2
110 VITREAL CELLS 2
111 VITREOUS OPACITIES 2
112 ABNORMAL SENSATION IN EYE 1
113 ALANINE AMINOTRANSFERASE INCREASED 1
114 AMNESIA 1
115 ANAPHYLACTIC REACTION 1
116 ANTERIOR CHAMBER CELL 1
117 ANTERIOR CHAMBER FLARE 1
118 ARTHRALGIA 1
119 ASTHENIA 1
120 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1
121 BALANCE DISORDER 1
122 BARRETT^S OESOPHAGUS 1
123 BELL^S PALSY 1
124 BLEPHARITIS 1
125 BLEPHAROSPASM 1
126 BLOOD PRESSURE DECREASED 1
127 BLOOD PRESSURE SYSTOLIC INCREASED 1
128 BULLOUS KERATOPATHY 1
129 CATARACT NUCLEAR 1
130 CHEST DISCOMFORT 1
131 CHOROIDITIS 1
132 CHROMATOPSIA 1
133 CHRONIC LYMPHOCYTIC LEUKAEMIA 1
134 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1
135 CONJUNCTIVAL HYPERAEMIA 1
136 CONJUNCTIVAL OEDEMA 1
137 CONJUNCTIVITIS 1
138 CYST 1
139 DEAFNESS 1
140 DEPRESSION 1
141 DERMATITIS CONTACT 1
142 DEVICE FAILURE 1
143 DISCOMFORT 1
144 DISEASE RECURRENCE 1
145 DIZZINESS 1
146 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
147 DRUG LEVEL INCREASED 1
148 DYSPNOEA 1
149 EPISCLERITIS 1
150 EXTRA DOSE ADMINISTERED 1
151 EYE ALLERGY 1
152 EYE EXCISION 1
153 EYE INFARCTION 1
154 EYE NAEVUS 1
155 EYELID MARGIN CRUSTING 1
156 EYELID OEDEMA 1
157 FACIAL PAIN 1
158 FOOT OPERATION 1
159 FOREIGN BODY SENSATION IN EYES 1
160 GENERALISED ANXIETY DISORDER 1
161 GIANT CELL ARTERITIS 1
162 HAEMORRHAGIC DIATHESIS 1
163 HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS 1
164 HALLUCINATION, VISUAL 1
165 HEART RATE DECREASED 1
166 HEPATIC ENZYME INCREASED 1
167 HERPES OPHTHALMIC 1
168 HERPES ZOSTER 1
169 HIATUS HERNIA 1
170 HYPERTENSION 1
171 HYPOAESTHESIA 1
172 HYPOAESTHESIA ORAL 1
173 HYPOPYON 1
174 IMMUNOSUPPRESSION 1
175 IMPAIRED DRIVING ABILITY 1
176 INADEQUATE ASEPTIC TECHNIQUE IN MANUFACTURING OF PRODUCT 1
177 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1
178 INCORRECT DOSE ADMINISTERED 1
179 INCREASED TENDENCY TO BRUISE 1
180 INJECTION SITE DISCHARGE 1
181 INJECTION SITE PRURITUS 1
182 INJECTION SITE REACTION 1
183 INJURY ASSOCIATED WITH DEVICE 1
184 INTENTIONAL PRODUCT USE ISSUE 1
185 INTERCEPTED PRODUCT PRESCRIBING ERROR 1
186 INTRAOCULAR PRESSURE TEST 1
187 INTRAOCULAR PRESSURE TEST ABNORMAL 1
188 IRRITABILITY 1
189 KERATITIS 1
190 KNEE ARTHROPLASTY 1
191 LIP SWELLING 1
192 LOSS OF CONSCIOUSNESS 1
193 LOSS OF VISUAL CONTRAST SENSITIVITY 1
194 MADAROSIS 1
195 MALAISE 1
196 MEDICATION ERROR 1
197 MELANOCYTIC NAEVUS 1
198 MYDRIASIS 1
199 NASOPHARYNGITIS 1
200 NECK PAIN 1
201 NECROTISING RETINITIS 1
202 NEOPLASM MALIGNANT 1
203 NIGHT SWEATS 1
204 OCULAR DISCOMFORT 1
205 OCULAR TOXICITY 1
206 OEDEMA 1
207 OPEN ANGLE GLAUCOMA 1
208 OPTIC NEUROPATHY 1
209 PACKAGING DESIGN ISSUE 1
210 PALPITATIONS 1
211 PANIC DISORDER 1
212 PHOTOPHOBIA 1
213 PHOTOSENSITIVITY REACTION 1
214 PLASMA CELL MYELOMA 1
215 POLLAKIURIA 1
216 PRODUCT CONTAINER SEAL ISSUE 1
217 PRODUCT PRESCRIBING ISSUE 1
218 PRODUCT RESIDUE PRESENT 1
219 PRURITUS 1
220 PULMONARY EMBOLISM 1
221 RASH ERYTHEMATOUS 1
222 RETINAL INFARCTION 1
223 RETINAL THICKENING 1
224 RHEUMATOID ARTHRITIS 1
225 SCAB 1
226 SKIN CANCER 1
227 SKIN EXFOLIATION 1
228 SKIN LACERATION 1
229 SKIN ULCER 1
230 SKIN WEEPING 1
231 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1
232 STAPHYLOCOCCUS TEST POSITIVE 1
233 STRESS 1
234 SUSPECTED PRODUCT CONTAMINATION 1
235 THERAPEUTIC RESPONSE DECREASED 1
236 THERAPY INTERRUPTED 1
237 THERAPY PARTIAL RESPONDER 1
238 THIRST 1
239 TINNITUS 1
240 TREMOR 1
241 VISUAL ACUITY REDUCED TRANSIENTLY 1
242 VITREOUS DISORDER 1
243 VITREOUS HAZE 1
244 VOMITING 1
245 WEIGHT DECREASED 1
246 WEIGHT INCREASED 1
247 WHEEZING 1
248 WHITE BLOOD CELL COUNT INCREASED 1
249 WOUND 1